1. Home
  2. EPRT vs SYRE Comparison

EPRT vs SYRE Comparison

Compare EPRT & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Properties Realty Trust Inc.

EPRT

Essential Properties Realty Trust Inc.

HOLD

Current Price

$26.90

Market Cap

6.9B

Sector

Real Estate

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

BUY

Current Price

$87.83

Market Cap

8.0B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
EPRT
SYRE
Founded
2016
2013
Country
United States
United States
Employees
N/A
112
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
8.0B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
EPRT
SYRE
Price
$26.90
$87.83
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
12
Target Price
$36.79
$85.08
AVG Volume (30 Days)
1.6M
1.2M
Earning Date
04-22-2026
05-08-2026
Dividend Yield
3.98%
N/A
EPS Growth
11.30
N/A
EPS
0.62
N/A
Revenue
$561,219,000.00
N/A
Revenue This Year
$17.12
N/A
Revenue Next Year
$16.27
N/A
P/E Ratio
$43.34
N/A
Revenue Growth
24.82
N/A
52 Week Low
$26.47
$15.49
52 Week High
$34.73
$110.18

Technical Indicators

Market Signals
Indicator
EPRT
SYRE
Relative Strength Index (RSI) N/A 45.93
Support Level N/A $82.83
Resistance Level N/A $92.10
Average True Range (ATR) 0.00 3.30
MACD 0.00 0.48
Stochastic Oscillator 0.00 65.46

Price Performance

Historical Comparison
EPRT
SYRE

About EPRT Essential Properties Realty Trust Inc.

Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: